Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 29.88
+0.81 (2.79%)
Apr 29, 2026, 4:00 PM EDT
SHE:301258 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 412.51 | 432.73 | 426.01 | 483.1 | 548.95 | 511.66 | Upgrade
|
| Other Revenue | - | - | 3.46 | 6.19 | 19.26 | 10.03 | Upgrade
|
| Revenue | 412.51 | 432.73 | 429.47 | 489.29 | 568.21 | 521.7 | Upgrade
|
| Revenue Growth (YoY) | -7.56% | 0.76% | -12.23% | -13.89% | 8.92% | 9.40% | Upgrade
|
| Cost of Revenue | 343.34 | 360.52 | 348.04 | 301.22 | 314.9 | 314.25 | Upgrade
|
| Gross Profit | 69.17 | 72.21 | 81.43 | 188.07 | 253.31 | 207.45 | Upgrade
|
| Selling, General & Admin | 47.02 | 44.52 | 46.58 | 50.89 | 47.65 | 37.44 | Upgrade
|
| Research & Development | 35.06 | 35.8 | 40.62 | 40.7 | 41.37 | 28.51 | Upgrade
|
| Other Operating Expenses | -0.32 | -0.01 | 1.89 | 4.78 | 5.1 | 4.11 | Upgrade
|
| Operating Expenses | 81.75 | 80.31 | 90.59 | 95.18 | 94.54 | 70.41 | Upgrade
|
| Operating Income | -12.59 | -8.1 | -9.16 | 92.89 | 158.77 | 137.04 | Upgrade
|
| Interest Expense | - | - | -0.09 | -0.12 | -0.31 | -0.45 | Upgrade
|
| Interest & Investment Income | 40.03 | 31.8 | 46.94 | 28.96 | 8.2 | 4.62 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 3.36 | 1.48 | 31.6 | -5.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.7 | 2.3 | -0.2 | -0.19 | -0.09 | -0.27 | Upgrade
|
| EBT Excluding Unusual Items | 25.74 | 26 | 40.85 | 123.02 | 198.17 | 135.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | 16.58 | 46.72 | -10.3 | 6.31 | -0.86 | 1.61 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.29 | -0.3 | -0.93 | -0.39 | - | - | Upgrade
|
| Asset Writedown | 1.6 | 2.43 | -14.36 | -3.97 | -1.85 | -1.11 | Upgrade
|
| Other Unusual Items | - | - | 2.95 | 3.58 | 7.01 | 2.49 | Upgrade
|
| Pretax Income | 43.63 | 74.85 | 18.21 | 128.54 | 202.46 | 138.44 | Upgrade
|
| Income Tax Expense | 6.04 | 10.55 | 1.81 | 16.36 | 25.15 | 18.24 | Upgrade
|
| Net Income | 37.59 | 64.29 | 16.41 | 112.18 | 177.31 | 120.2 | Upgrade
|
| Net Income to Common | 37.59 | 64.29 | 16.41 | 112.18 | 177.31 | 120.2 | Upgrade
|
| Net Income Growth | 8.78% | 291.89% | -85.38% | -36.73% | 47.51% | -14.78% | Upgrade
|
| Shares Outstanding (Basic) | 90 | 91 | 91 | 92 | 86 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 90 | 91 | 91 | 92 | 86 | 69 | Upgrade
|
| Shares Change (YoY) | -0.98% | -0.65% | -0.88% | 6.83% | 25.31% | -0.17% | Upgrade
|
| EPS (Basic) | 0.42 | 0.71 | 0.18 | 1.22 | 2.06 | 1.75 | Upgrade
|
| EPS (Diluted) | 0.42 | 0.71 | 0.18 | 1.22 | 2.06 | 1.75 | Upgrade
|
| EPS Growth | 9.85% | 294.44% | -85.25% | -40.78% | 17.71% | -14.63% | Upgrade
|
| Free Cash Flow | -129.39 | -79.9 | -58.25 | 53.15 | 101.08 | 118.98 | Upgrade
|
| Free Cash Flow Per Share | -1.44 | -0.88 | -0.64 | 0.58 | 1.17 | 1.73 | Upgrade
|
| Dividend Per Share | - | - | 0.091 | 0.600 | 0.580 | 0.400 | Upgrade
|
| Dividend Growth | - | - | -84.83% | 3.45% | 45.00% | -42.86% | Upgrade
|
| Gross Margin | 16.77% | 16.69% | 18.96% | 38.44% | 44.58% | 39.77% | Upgrade
|
| Operating Margin | -3.05% | -1.87% | -2.13% | 18.98% | 27.94% | 26.27% | Upgrade
|
| Profit Margin | 9.11% | 14.86% | 3.82% | 22.93% | 31.20% | 23.04% | Upgrade
|
| Free Cash Flow Margin | -31.37% | -18.46% | -13.56% | 10.86% | 17.79% | 22.81% | Upgrade
|
| EBITDA | 34.66 | 39.27 | 38.69 | 148.89 | 210.37 | 183.15 | Upgrade
|
| EBITDA Margin | 8.40% | 9.07% | 9.01% | 30.43% | 37.02% | 35.11% | Upgrade
|
| D&A For EBITDA | 47.25 | 47.37 | 47.85 | 56 | 51.61 | 46.11 | Upgrade
|
| EBIT | -12.59 | -8.1 | -9.16 | 92.89 | 158.77 | 137.04 | Upgrade
|
| EBIT Margin | -3.05% | -1.87% | -2.13% | 18.98% | 27.94% | 26.27% | Upgrade
|
| Effective Tax Rate | 13.84% | 14.10% | 9.92% | 12.73% | 12.43% | 13.18% | Upgrade
|
| Revenue as Reported | - | - | 429.47 | 489.29 | 568.21 | 521.7 | Upgrade
|
| Advertising Expenses | - | - | - | - | 1.19 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.